SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 12 closing their positions.
Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
19
Reduced
20
Closed
12
Calls
$2.2M
Puts
$2K
Net Calls
+$2.2M
Net Calls Change
-$795K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FHA
76
Flagship Harbor Advisors
Boston,
Massachusetts
| – | – | -14,750 | Closed |
|
|
MC
77
Moors & Cabot
Boston,
Massachusetts
| – | – | -5,250 | Closed |
|
|
WVP
78
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | -4,673 | Closed |
|
|
PAG
79
Private Advisor Group
Morristown,
New Jersey
| – | – | -1,750 | Closed |
|
|
AIC
80
Archer Investment Corporation
Carmel,
Indiana
| – | – | -420 | Closed |
|
|
CAN
81
Cetera Advisor Networks
El Segundo,
California
| – | – | -410 | Closed |
|
|
CAGAS
82
Capital Advisory Group Advisory Services
Bloomington,
Minnesota
| – | – | -147 | Closed |
|
83
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | – | -74 | Closed |
|
|
TFA
84
Transamerica Financial Advisors
St. Petersburg,
Florida
| – | – | -1 | Closed |
|
|
HNB
85
Huntington National Bank
Columbus,
Ohio
| – | – | – | – |
|